CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +2,990 | 72,334 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +9,727 | 82,061 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +26,600 | 108,661 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +28,690 | 137,351 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Shares withheld for taxes | −16,560 | $7.19 | $119K | 120,791 |
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −2,990 | 0 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −9,727 | 0 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −26,600 | 26,600 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −28,690 | 57,380 | ||
| 2021-02-11 | TYLE PRAVEEN EVP, R&D | Grant or award · Restricted Stock Units | +32,100 | 32,100 | ||
| 2021-02-11 | TYLE PRAVEEN EVP, R&D | Grant or award · Stock Option (Right to Buy) | +96,310 | 96,310 | ||
| 2020-04-22 | TYLE PRAVEEN EVP, R&D | Grant or award | +19,893 | 74,188 | ||
| 2020-04-22 | TYLE PRAVEEN EVP, R&D | Shares withheld for taxes | −4,844 | $1.96 | $9K | 69,344 |
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +2,990 | 17,969 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +9,726 | 27,695 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +26,600 | 54,295 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −2,990 | 2,990 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −9,726 | 9,727 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −26,600 | 53,200 | ||
| 2020-02-06 | TYLE PRAVEEN EVP, R&D | Grant or award · Restricted Stock Units | +86,070 | 86,070 |
Page 1 of 2 · 27 trades